| |
|
|
|
|
|
|
|||
|
Blood, 9 July 2009, Vol. 114, No. 2, pp. 452-458. Prepublished online as a Blood First Edition Paper on April 7, 2009; DOI 10.1182/blood-2009-02-203604.
Submitted February 4, 2009
Department of Pathology, Vanderbilt University, Nashville, TN, United States * Corresponding author; email: dave.gailani{at}vanderbilt.edu.
During surface-initiated blood coagulation in vitro, activated factor XII (fXIIa) converts factor XI (fXI) to fXIa. While fXI deficiency is associated with a hemorrhagic disorder, factor XII deficiency is not, suggesting fXI can be activated by other mechanisms in vivo. Thrombin activates fXI, and several studies suggest that fXI promotes coagulation independent of fXII. However, a recent study failed to find evidence for fXII-independent activation of fXI in plasma. Using plasma in which fXII is either inhibited or absent, we show that fXI contributes to plasma thrombin generation when coagulation is initiated with low concentrations of tissue factor, factor Xa or
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||